259 related articles for article (PubMed ID: 34729671)
41. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
Qiu MT; Fan Q; Zhu Z; Kwan SY; Chen L; Chen JH; Ying ZL; Zhou Y; Gu W; Wang LH; Cheng WW; Zeng J; Wan XP; Mok SC; Wong KK; Bao W
Oncotarget; 2015 Oct; 6(31):31702-20. PubMed ID: 26397136
[TBL] [Abstract][Full Text] [Related]
42. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
Zhu X; Du J; Gu Z
Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
[TBL] [Abstract][Full Text] [Related]
43. KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma.
Fu X; Zhu Y; Zheng B; Zou Y; Wang C; Wu P; Wang J; Chen H; Du P; Liang B; Fang L
Int J Oncol; 2018 Jun; 52(6):1912-1922. PubMed ID: 29620256
[TBL] [Abstract][Full Text] [Related]
44. HNRNPC Regulates GLUT1/LDHA Pathway by Stabilizing FOXM1 mRNA to Promote the Progression and Aerobic Glycolysis of Multiple Myeloma.
Wu N; Zhu Y
Ann Clin Lab Sci; 2024 Jan; 54(1):56-65. PubMed ID: 38514068
[TBL] [Abstract][Full Text] [Related]
45. Transcription Factor STAT3-Activated LDHB Promotes Tumor Properties of Endometrial Cancer Cells by Inducing MDH2 Expression.
Shen L; Wang J; Li Y; Sun C; Teng M; Ye X; Feng X
Mol Biotechnol; 2024 Feb; ():. PubMed ID: 38381377
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients.
Liu X; Yao D; Liu C; Cao Y; Yang Q; Sun Z; Liu D
Tumour Biol; 2016 Jun; 37(6):8367-74. PubMed ID: 26733163
[TBL] [Abstract][Full Text] [Related]
47. Clinical significance of Sam68 expression in endometrial carcinoma.
Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
[TBL] [Abstract][Full Text] [Related]
48. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
49. Knockdown of differentiation antagonizing non-protein coding RNA exerts anti-tumor effect by up-regulating miR-214 in endometrial carcinoma.
Sun J; Gao S; Lu C
Mol Cell Biochem; 2019 Oct; 460(1-2):9-15. PubMed ID: 31161373
[TBL] [Abstract][Full Text] [Related]
50. CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression.
Zhang Y; Zhao L; Yang S; Cen Y; Zhu T; Wang L; Xia L; Liu Y; Zou J; Xu J; Li Y; Cheng X; Lu W; Wang X; Xie X
J Exp Clin Cancer Res; 2020 Dec; 39(1):281. PubMed ID: 33308298
[TBL] [Abstract][Full Text] [Related]
51. Methylglyoxal suppresses human colon cancer cell lines and tumor growth in a mouse model by impairing glycolytic metabolism of cancer cells associated with down-regulation of c-Myc expression.
He T; Zhou H; Li C; Chen Y; Chen X; Li C; Mao J; Lyu J; Meng QH
Cancer Biol Ther; 2016 Sep; 17(9):955-65. PubMed ID: 27455418
[TBL] [Abstract][Full Text] [Related]
52. PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis.
Qin Y; Hu Q; Xu J; Ji S; Dai W; Liu W; Xu W; Sun Q; Zhang Z; Ni Q; Zhang B; Yu X; Xu X
Cell Commun Signal; 2019 Mar; 17(1):30. PubMed ID: 30922330
[TBL] [Abstract][Full Text] [Related]
53. Knocking down of LINC01220 inhibits proliferation and induces apoptosis of endometrial carcinoma through silencing MAPK11.
Li Y; Kong C; Wu C; Wang Y; Xu B; Liang S; Ying X
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31123170
[No Abstract] [Full Text] [Related]
54. Over-expression of miR-1271 inhibits endometrial cancer cells proliferation and induces cell apoptosis by targeting CDK1.
Li L; Qu YW; Li YP
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2816-2822. PubMed ID: 28682437
[TBL] [Abstract][Full Text] [Related]
55. The overexpression of KIFC1 was associated with the proliferation and prognosis of non-small cell lung cancer.
Liu Y; Zhan P; Zhou Z; Xing Z; Zhu S; Ma C; Li Q; Zhu Q; Miao Y; Zhang J; Lv T; Song Y
J Thorac Dis; 2016 Oct; 8(10):2911-2923. PubMed ID: 27867568
[TBL] [Abstract][Full Text] [Related]
56. miR-544a Stimulates endometrial carcinoma growth via targeted inhibition of reversion-inducing cysteine-rich protein with Kazal motifs.
Zheng WP; Meng FL; Wang LY
Mol Cell Probes; 2020 Oct; 53():101572. PubMed ID: 32525042
[TBL] [Abstract][Full Text] [Related]
57. [Apolipoprotein E enhances migration of endometrial cancer cells byactivating the ERK/MMP9 signaling pathway].
Wu C; Cheng W
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Feb; 43(2):232-241. PubMed ID: 36946043
[TBL] [Abstract][Full Text] [Related]
58. GLUT1 regulates cell glycolysis and proliferation in prostate cancer.
Xiao H; Wang J; Yan W; Cui Y; Chen Z; Gao X; Wen X; Chen J
Prostate; 2018 Feb; 78(2):86-94. PubMed ID: 29105798
[TBL] [Abstract][Full Text] [Related]
59. miR-489 suppresses multiple myeloma cells growth through inhibition of LDHA-mediated aerobic glycolysis.
Wu H; Wang X; Wu T; Yang S
Genes Genomics; 2020 Mar; 42(3):291-297. PubMed ID: 31872383
[TBL] [Abstract][Full Text] [Related]
60. PGC1β regulates multiple myeloma tumor growth through LDHA-mediated glycolytic metabolism.
Zhang H; Li L; Chen Q; Li M; Feng J; Sun Y; Zhao R; Zhu Y; Lv Y; Zhu Z; Huang X; Xie W; Xiang W; Yao P
Mol Oncol; 2018 Sep; 12(9):1579-1595. PubMed ID: 30051603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]